Domine Gomez, Manuel manuel.domine@uam.es

Publications

Tratamiento médico del carcinoma microcítico de pulmón. Carcinoma microcítico de pulmón

  • Dómine Gómez, Manuel
  • López-Vilariño de Ramos, José Antonio
  • Ramírez Merino, Natalia
  • Fuentes Mateos, Raquel
  • Lobo Samper, Francisco

Revisiones En Cancer (p. 237-246) - 1/1/2009

  • ISSN 02138573
  • iMarina

Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis

  • Arriola, E
  • Gonzalez-Cao, M
  • Domine, M
  • De Castro, J
  • Cobo, M
  • Bernabe, R
  • Navarro, A
  • Sullivan, I
  • Trigo, JM
  • Mosquera, J
  • Crama, L
  • Isla, D
... View more Collapse

Oncology And Therapy (p. 167-184) - 1/6/2022

10.1007/s40487-021-00182-0 View at source

  • ISSN 23661089

Extensive pleural effusion as first manifestation of wall rhabdomyosarcoma

  • Casal Rubio J
  • Domine Gomez M
  • Lopez Sacconi F
  • Jerves Andrade M
  • Vicente J

Oncologia (p. 403-408) - 1/1/1988

  • ISSN 03784835
  • iMarina

Anatomopathologic, clinical and therapeutic considerations on malignant tumors of the parotid. Our experience

  • Arias de la Vega F
  • Albert Solis J
  • Perez Casas A
  • Martinez Lopez E
  • Domine Gomez M
  • Melchor Iniguez M

Oncologia (p. 145-151) - 1/1/1988

  • ISSN 03784835
  • iMarina

NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment

  • Sanchez-Herrero, Estela
  • Serna-Blasco, Roberto
  • Ivanchuk, Vadym
  • Garcia-Campelo, Rosario
  • Gomez, Manuel Domine
  • Sanchez, Jose M.
  • Massuti, Bartomeu
  • Reguart, Noemi
  • Camps, Carlos
  • Sanz-Moreno, Sandra
  • Calabuig-Farinas, Silvia
  • Jantus-Lewintre, Eloisa
  • Arnal, Magdalena
  • Fernandez-Orth, Dietmar
  • Calvo, Virginia
  • Gonzalez-Rumayor, Victor
  • Provencio, Mariano
  • Romero, Atocha;
... View more Collapse

Molecular Oncology (p. 2363-2376) - 1/9/2021

10.1002/1878-0261.13033 View at source

  • ISSN 15747891

Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)

  • de la Rosa, CA
  • Castellanos, PC
  • Lazaro-Quintela, M
  • Domine, M
  • Estevez, SV
  • Lopez-Vivanco, G
  • Perez, JLF
  • Romero, JLA
  • Delgado, LF
  • Giron, CG
  • Tain, PD
  • Alvarez, RA
  • Sanchis, PM
  • Canton, IF
  • Abos, IM
  • Aguillo, MM
  • Gutierrez, LGA
  • Granados, ALO
  • Cabellos, RA
  • Sebastian, AG
  • Sifuentes, LFG
  • Reguart, N
... View more Collapse

Lung Cancer (p. 83-93) - 1/11/2022

10.1016/j.lungcan.2022.09.010 View at source

  • ISSN 01695002

Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial

  • Aix SP
  • Ciuleanu TE
  • Navarro A
  • Cousin S
  • Bonanno L
  • Smit EF
  • Chiappori A
  • Olmedo ME
  • Horvath I
  • Grohé C
  • Farago AF
  • López-Vilariño JA
  • Cullell-Young M
  • Nieto A
  • Vasco N
  • Gómez J
  • Kahatt C
  • Zeaiter A
  • Carcereny E
  • Roubec J
  • Syrigos K
  • Lo G
  • Barneto I
  • Pope A
  • Sánchez A
  • Kattan J
  • Zarogoulidis K
  • Waller CF
  • Bischoff H
  • Juan-Vidal O
  • Reinmuth N
  • Dómine M
  • Paz-Ares L
... View more Collapse

Lancet Respiratory Medicine (p. 74-86) - 1/1/2023

10.1016/s2213-2600(22)00309-5 View at source

  • ISSN 22132600

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

  • Goldman JW, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüro?lu M, Ji JH, Garassino MC, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Ka?arnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Thiyagarajah P, Jiang H, Paz-Ares L, CASPIAN investigators

Lancet Oncology (p. 51-65) - 1/1/2021

10.1016/s1470-2045(20)30539-8 View at source

  • ISSN 14702045

First-line Atezolizumab plus Bevacizumab for Metastatic High-Intermediate TMB in Non-squamous NSCLC. The TELMA Study

  • Provencio-pulla, M
  • Ortega, AL
  • Coves, J
  • Franco, F
  • Marse, R
  • Domine, M
  • Guirado, M
  • Carcereny, E
  • Fernandez, N
  • Martinez, E
  • Blanco, R
  • Leon, L
  • Sanchez, JM
  • Sullivan, I
  • Cobo, M
  • Sanchez, A
  • Massuti, B
... View more Collapse

Journal Of Thoracic Oncology (p. S123-S124) - 1/9/2022

  • ISSN 15560864
  • iMarina

Multidisciplinary Thoracic Tumors Board Survey in Spain

  • Massuti, B
  • Nadal, E
  • Camps, C
  • Carcereny, E
  • Cobo, M
  • Domine, M
  • Garcia-Campelo, MR
  • Gonzalez-Larriba, JL
  • Guirado, M
  • Hernando-Trancho, F
  • Rodriguez-Abreu, D
  • Sanchez, A
  • Sullivan, I
  • Provencio, M
... View more Collapse

Journal Of Thoracic Oncology (p. S107-S107) - 1/9/2022

  • ISSN 15560864
  • iMarina

Cáncer de pulmón de célula pequeña

  • Manuel Dómine Gómez
  • Pilar Garrido López

1/1/2006

Editor: Madrid : Editores Médicos, 2006

  • ISBN 8477142416
  • ISSN/ISBN 84-7714-241-6

This researcher has no book chapters.

This researcher has no conferences.

This researcher has no working papers.

This researcher has no technical reports.

This researcher has no research projects.

This researcher has no supervised thesis.

This researcher has no patents or software licenses.

Last data update: 9/21/23 2:03 PM